Cargando…
Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748230/ https://www.ncbi.nlm.nih.gov/pubmed/26847961 http://dx.doi.org/10.1038/ncomms10703 |
| _version_ | 1782415087135358976 |
|---|---|
| author | Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. |
| author_facet | Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. |
| author_sort | Janzen, D. M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4748230 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47482302016-02-24 Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. Nat Commun Corrigenda Nature Publishing Group 2016-02-05 /pmc/articles/PMC4748230/ /pubmed/26847961 http://dx.doi.org/10.1038/ncomms10703 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Corrigenda Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title | Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_full | Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_fullStr | Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_full_unstemmed | Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_short | Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_sort | corrigendum: an apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748230/ https://www.ncbi.nlm.nih.gov/pubmed/26847961 http://dx.doi.org/10.1038/ncomms10703 |
| work_keys_str_mv | AT janzendm corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT tiourine corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT salehija corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT paikdy corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT luj corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT pellegrinim corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT memarzadehs corrigendumanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer |